• ##navigation.register##
  • ##navigation.login##
    • en
    • uz
    • ru
  • en
  • uz
  • ru
##navigation.register## ##navigation.login##
  • Joriy
  • ##navigation.archives##
    • ##about.aboutContext##
    • ##about.submissions##
    • ##common.editorialMasthead##
    • ##manager.setup.privacyStatement##
    • ##about.contact##
Joriy ##navigation.archives##
##about.aboutContext## ##about.submissions## ##common.editorialMasthead## ##manager.setup.privacyStatement## ##about.contact##
  1. ##common.homepageNavigationLabel##
  2. ##common.search##

##common.search##

##search.advancedFilters##
##search.dateFrom##
##search.dateTo##

##search.searchResults##

##search.searchResults.foundSingle##
  • EVALUATION OF THE RESULTS OF COMBINED NEUROMETABOLIC THERAPY IN CHILDREN WITH TICS: DYNAMICS OF MOTOR AND PSYCHOPATHOLOGICAL SYMPTOMS

    Nurmatova D.A.

    tic hyperkinesis represents one of the most prevalent forms of extrapyramidal pathology in the pediatric population. In recent years, there has been growing clinical and research interest in the non-motor manifestations of tic disorders, which frequently include comorbid attention-deficit/hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), and anxiety disorders. A prevailing hypothesis suggests these neuropsychiatric conditions may share a common underlying pathophysiology. Nevertheless, establishing effective therapeutic strategies for these complex comorbid presentations in children with tic hyperkinesis remains a significant clinical challenge. The aim of this study was to evaluate the efficacy of combination pharmacotherapy in improving the core and comorbid symptoms of tic disorders in children, thereby contributing to enhanced therapeutic outcomes. The results of this study indicate that adjunctive therapy with hopantenic acid, in combination with first-line treatment, is effective for the comprehensive management of both motor tics and the common comorbid symptoms of ADHD, OCD, and anxiety in children with tic hyperkinesis. These findings support the utility of a targeted, multi-symptom treatment approach for this patient population.

    38-42
    11-02-2026
    Davomini o‘qing
##navigation.items##

Ma'lumot

  • ##navigation.infoForReaders##
  • Mualliflar uchun
  • Kutubxonachilar uchun

So'nggi nashrlar

  • Atom logotipi
  • RSS2 logotipi
  • RSS1 logotipi
TNMU Publishing

Biz tibbiyotning rivojlanishini tezlashtirish va jamiyat salomatligini yaxshilash uchun tadqiqotchilar, bilim va texnologiyalarni birlashtiramiz.

 

Navigatsiya

Bosh sahifa
Jurnallar
Konferensiyalar
Mualliflar
Taqrizchilar
Nashriyot xizmatlari

Madad

Ijodkor qoidalari
Nashr axloqi
Biz haqimizda
Savol-javob
Qayta aloqa

Kontaktlar

 
O‘zbekiston, Toshkent,,
Olmazor tumani, Shifokorlar ko‘chasi, 21-uy
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
##user.login##
Markaziy Osiyo Pulmonologlari Uyushmasining Axborotnomasi
##user.login##
* ##common.required##
* ##common.required##
##user.login.forgotPassword##
##user.login.rememberUsernameAndPassword##
##user.login.registerNewAccount##